The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
April 22nd 2025
The in vivo gene editing program is designed to eliminate cccDNA and inactive integrated hepatitis B DNA.
FDA OKs Expanded Indication for Short Bowel Syndrome Treatment to Include Children
May 17th 2019Officials with the FDA have approved extending the indication of Takeda Pharmaceuticals’ teduglutide (Gattex) for injection to pediatric patients age 1 year and older with Short Bowel Syndrome who need additional nutrition or fluids from intravenous feeding.
Read More
NHIA 2019: Empowering Pharmacies to Grow in Specialty
May 17th 2019The convenience of home infusion for these products is very enticing for patients who require them and positioning home infusion pharmacies as partners with prescribers and patients is critical to help support this influx of new therapies.
Read More
Pifeltro and Delstrigo: New Options for HIV-1
May 14th 2019On August 30, 2018, the FDA approved Merck’s doravirine (Pifeltro) a non-nucleoside reverse transcriptase inhibitor and doravirine/lamivudine/tenofovir (Delstrigo) a once-daily single tablet regimen for the treatment of HIV-1 infection in appropriate patients.
Read More